Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial

AIM: To evaluate the therapeutic efficacy, safety and tolerability of newly developed preservative-free (PF) latanoprost generic [TJO-002] and compare it with benzalkonium chloride (BAK)-preserved latanoprost [Xalatan®] in patients with primary open angle glaucoma (POAG) and ocular hypertension (OHT...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Joon Mo Kim, Kyung Rim Sung, Ji Woong Lee, Haksu Kyung, Seungsoo Rho, Chan Yun Kim
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Press of International Journal of Ophthalmology (IJO PRESS) 2021-10-01
coleção:	International Journal of Ophthalmology
Assuntos:	latanoprost benzalkonium chloride intraocular pressure preservative-free
Acesso em linha:	http://ies.ijo.cn/en_publish/2021/10/20211010.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!